EUVIMEDEUVIMED entdecken
Crossref

Advancing breast cancer circulating tumour cell research at the Institute of Oncology Ljubljana

Tanja Jesenko, Cvetka Grašič Kuhar, Ziva Pisljar, Simona Miceska, Veronika Kloboves Prevodnik, Čemažar, Maja

DiRROS repository (University of Maribor) · 19.12.2024

DOI: 10.25670/oi2024-010on ↗

Kurz gefasst

Fachartikel in der Zeitschrift DiRROS repository (University of Maribor), erschienen am 19.12.2024. Verfasst von Tanja Jesenko und 6 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Circulating tumour cells (CTCs) have become an important biomarker in breast cancer, providing an insight into disease progression and monitoring of therapeutic response. Due to their extreme rarity in blood and the complexity of blood composition, their isolation and characterization is challenging. Specific isolation methods allow the enrichment of CTCs from a blood sample and facilitate further analysis. At the Institute of Oncology Ljubljana, in 2018 we initiated efforts to develop a simple method for the isolation and characterization of CTCs, aimed at identifying these cells through cytopathological analysis. We evaluated two different methods of CTC isolation in breast cancer patients based on different approaches. The first method is based on cell biological properties, such as the expression of the epithelial cell adhesion marker (EpCAM), while the second method is based on physical properties of CTCs, such as their larger size and deformability compared to other blood cells. We found that the physical method is more suitable, as it enables the isolation of higher numbers of morphologically intact CTCs. After isolation, cytological slides are prepared and then characterized by cytopathological analysis and immunocytochemical and immunofluorescence staining. This approach currently allows us to determine the number of single CTCs and CTC clusters in the blood, assess their morphological preservation, and identify their phenotype. In addition to evaluation of single CTCs and CTC clusters in ongoing clinical trials using currently established methods and the planned establishment of a translational platform in mouse models, we aim to expand the range of CTC studies in the future to include genomic and transcriptomic analysis.

Schlagwörter

circulating tumor cellsbreast cancerCTC isolationCTC clustersEpCAMdeformation capacityimmunocytochemistryimmunofluorescencetumour biomarkerstreatment response monitoring

Zitieren

APA

Jesenko, T., Kuhar, C. G., Pisljar, Z., Miceska, S., Prevodnik, V. K., Čemažar, & Maja (2024). Advancing breast cancer circulating tumour cell research at the Institute of Oncology Ljubljana. DiRROS repository (University of Maribor). https://doi.org/10.25670/oi2024-010on

Vancouver

Jesenko T, Kuhar CG, Pisljar Z, Miceska S, Prevodnik VK, Čemažar, et al. Advancing breast cancer circulating tumour cell research at the Institute of Oncology Ljubljana. DiRROS repository (University of Maribor). 2024. doi:10.25670/oi2024-010on

BibTeX
@article{Jesenko2024,
  author = {Jesenko, Tanja and Kuhar, Cvetka Grašič and Pisljar, Ziva and Miceska, Simona and Prevodnik, Veronika Kloboves and Čemažar and Maja},
  title = {Advancing breast cancer circulating tumour cell research at the Institute of Oncology Ljubljana},
  journal = {DiRROS repository (University of Maribor)},
  year = {2024},
  doi = {10.25670/oi2024-010on}
}
Kostenlos starten →